Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

  • CN 1,856,323 A
  • Filed: 07/25/2004
  • Published: 11/01/2006
  • Est. Priority Date: 07/25/2003
  • Status: Active Application
First Claim
Patent Images

1. , immunogenic composition, it comprises carrier and as the conjugate of antigenic structure, described conjugate comprises at least one all or part of aminoacid sequence derived from the peptide of P-170 albumen born of the same parents outer shroud, wherein each peptide is in conjunction with the bimolecular at least fatty acid that contains carbochain between the C12-C24, thereby can induce anti--P-170 antibody under suitable administration condition.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×